EUVIMEDEUVIMED entdecken
Open Access

Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population

Arash Mostaghimi, Wei Gao, Markqayne Ray, Lauren Bartolome, Travis Wang, Christopher Carley, Nicolae Done, Elyse Swallow

JAMA Dermatology · 01.04.2023 · 159 (4) · 411

DOI: 10.1001/jamadermatol.2023.0002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Dermatology, erschienen am 01.04.2023. Verfasst von Arash Mostaghimi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Brigham and Women's Hospital, Harvard University, Boston, Massachusetts. Hauptthemen laut MEDLINE: Alopecia Areata. Die Arbeit wurde bisher 98-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Alopecia areata (AA) is characterized by nonscarring hair loss of the scalp, face, and/or body. Alopecia totalis (AT) and alopecia universalis (AU) involve complete loss of the scalp and body hair, respectively. The epidemiology of AA in the US remains unclear, having previously been extrapolated from older studies that were limited to specific geographic areas or clinical settings, or from self-reported data.

Objective

To estimate the annual prevalence and incidence of AA and AT and/or AU (AT/AU) in the US. Design, Setting, and Participants This retrospective, population-based cohort study was conducted from January 2016 to December 2019 and included enrollees in the IBM MarketScan Commercial Claims and Encounters and Medicare Supplemental databases and their dependents, with plan enrollment during each study calendar year and the year prior. Exposures Prevalent cases were identified by 1 or more claims for AA or AT/AU ( International Statistical Classification of Diseases, Tenth Revision, Clinical Modification [ICD-10-CM] codes L63.x, L63.0, L63.1) during each year of interest or the year prior. Incident cases were identified by 1 or more claims for AA or AT/AU during a specific year and no diagnosis the year prior. Main Outcomes and Measures Annual incidence and prevalence rates were calculated and stratified by age, sex, and region. National employer-sponsored insurance population estimates were obtained using population-based weights.

Results

Among eligible patients (2016: n = 18 368 [mean (SD) age, 40.6 (17.9) years; 12 295 women (66.9%)]; 2017: n = 14 372 [mean (SD) age, 39.6 (17.7) years; 9195 women (64.0%)]; 2018: n = 14 231 [mean (SD) age, 38.9 (17.3) years; 8998 women (63.2%)]; 2019: n = 13 455 [mean (SD) age, 39.1 (17.4) years; 8322 women (61.9%)]), AA prevalence increased from 0.199% (95% CI, 0.198%-0.200%) in 2016 to 0.222% (95% CI, 0.221%-0.223%) in 2019. Roughly 5% to 10% of prevalent and incident cases of AA were AT/AU. The prevalence of AT/AU increased from 0.012% (95% CI, 0.012%-0.013%) to 0.019% (95% CI, 0.018%-0.019%) from 2016 to 2019. Incidence of AA per 100 000 person-years ranged from 87.39 (95% CI, 86.84-87.96) in 2017 to 92.90 (95% CI, 92.35-93.45) in 2019. Incidence of AT/AU ranged from 7.09 (95% CI, 6.94-7.25) in 2017 to 8.92 (95% CI, 8.75-9.09) in 2016. Prevalence and incidence of AA and AT/AU were higher among female vs male individuals, adults vs children and adolescents, and in the Northeast vs other regions. Conclusions and Relevance The results of this cohort study suggest that these recent AA prevalence and incidence estimates could help improve current understanding of the disease burden. Further research is warranted to elucidate subpopulation differences and trends in AA in the broader US population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alopecia AreataAgedAdolescentHumansFemaleAdultMaleChildUnited StatesRetrospective StudiesIncidencePrevalenceCohort StudiesMedicareAlopecia

Autor:innen und Institutionen

  • Brigham and Women's Hospital, Harvard University, Boston, Massachusetts.
  • Analysis Group Inc, Boston, Massachusetts.
  • Pfizer Inc, Collegeville, Pennsylvania.
  • Pfizer Inc, New York, New York.

Zitieren

APA

Mostaghimi, A., Gao, W., Ray, M., Bartolome, L., Wang, T., Carley, C., Done, N., & Swallow, E. (2023). Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population. JAMA Dermatology, 159(4), 411. https://doi.org/10.1001/jamadermatol.2023.0002

Vancouver

Mostaghimi A, Gao W, Ray M, Bartolome L, Wang T, Carley C, et al. Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population. JAMA Dermatology. 2023;159(4):411. doi:10.1001/jamadermatol.2023.0002

BibTeX
@article{Mostaghimi2023,
  author = {Mostaghimi, Arash and Gao, Wei and Ray, Markqayne and Bartolome, Lauren and Wang, Travis and Carley, Christopher and Done, Nicolae and Swallow, Elyse},
  title = {Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population},
  journal = {JAMA Dermatology},
  year = {2023},
  volume = {159},
  number = {4},
  pages = {411},
  doi = {10.1001/jamadermatol.2023.0002}
}
Kostenlos starten →